Universe Pharmaceuticals INC

Nasdaq:UPC

Pharmaceutical Preparations·JI'AN, JIANGXI, F4

The universe comprises all of existence: all forms of matter and energy, and the structures they form, from sub-atomic particles to entire galactic filaments. 020 billion years ago and that the universe has been expanding since then.

Prospectuses & Registrations

15 shown

Filed	Form	Description
12/9/24	424B5	PROSPECTUS SUPPLEMENT	→
6/25/24	424B4	424B4	→
5/14/24	F-1/A	AMENDMENT NO. 1 TO FORM F-1	→
4/24/24	F-1	REGISTRATION STATEMENT	→
10/27/22	F-3	REGISTRATION STATEMENT	→
3/24/21	424B4	424B4	→
↓

Ownership

3 shown

Filed	Form	Description
2/14/23	SC 13G/A	SC 13G/A	→
2/11/22	SC 13G	SCHEDULE 13G	→
12/28/21	SC 13G	UPC PURA VIDA 13G	→

Other Filings

12 shown

Filed	Form	Description
1/7/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
5/15/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/14/25	SCHEDULE 13G	SCHEDULE 13G	→
1/3/25	SCHEDULE 13G	SCHEDULE 13G	→
6/7/24	EFFECT	EFFECT	→
11/15/22	EFFECT	EFFECT	→
↓

Filing History(93 filings)

TypeDateAccessionPeriodSize

6-K

Feb 11, 2026

0001213900-26-014886REPORT OF FOREIGN PRIVATE ISSUER

Feb 11, 2026

16.3 KB

20-F

Jan 29, 2026

0001213900-26-009000ANNUAL REPORT

Sep 30, 2025

10.5 MB

SCHEDULE 13G/A

Jan 7, 2026

0001535610-26-000006

—

9.2 KB

6-K

Sep 3, 2025

0001213900-25-084040REPORT OF FOREIGN PRIVATE ISSUER

Sep 3, 2025

51.5 KB

6-K

Aug 26, 2025

0001213900-25-080750REPORT OF FOREIGN PRIVATE ISSUER

Aug 26, 2025

10.5 KB

6-K

Jul 29, 2025

0001213900-25-068704REPORT OF FOREIGN PRIVATE ISSUER

Jul 29, 2025

754.6 KB

6-K

Jul 3, 2025

0001213900-25-061480REPORT OF FOREIGN PRIVATE ISSUER

Jul 3, 2025

143.5 KB

SCHEDULE 13G/A

May 15, 2025

0000950170-25-072930

—

15.2 KB

20-F

Apr 29, 2025

0001213900-25-036798ANNUAL REPORT

Sep 30, 2024

10.9 MB

6-K

Mar 20, 2025

0001213900-25-025300REPORT OF FOREIGN PRIVATE ISSUER

Mar 20, 2025

17.0 KB

6-K

Mar 11, 2025

0001213900-25-022737REPORT OF FOREIGN PRIVATE ISSUER

Mar 11, 2025

21.3 KB

6-K

Mar 3, 2025

0001213900-25-019406REPORT OF FOREIGN PRIVATE ISSUER

Mar 3, 2025

9.7 KB

6-K

Feb 25, 2025

0001213900-25-017079REPORT OF FOREIGN PRIVATE ISSUER

Feb 25, 2025

26.2 KB

6-K

Feb 20, 2025

0001213900-25-015667REPORT OF FOREIGN PRIVATE ISSUER

Feb 20, 2025

10.1 KB

6-K

Feb 18, 2025

0001213900-25-014864REPORT OF FOREIGN PRIVATE ISSUER

Feb 18, 2025

10.0 KB

SCHEDULE 13G

Feb 14, 2025

0000950170-25-021487

—

125.5 KB

6-K

Feb 11, 2025

0001213900-25-012207CURRENT REPORT

Feb 11, 2025

185.7 KB

6-K

Feb 3, 2025

0001213900-25-009434REPORT OF FOREIGN PRIVATE ISSUER

Feb 3, 2025

24.6 KB

6-K

Jan 30, 2025

0001213900-25-008083CURRENT REPORT

Jan 30, 2025

244.3 KB

NT 20-F

Jan 27, 2025

0001213900-25-006745NOTIFICATION OF LATE FILING

Sep 30, 2024

23.0 KB

SCHEDULE 13G

Jan 3, 2025

0001535610-25-000026

—

9.2 KB

6-K

Dec 12, 2024

0001213900-24-108402REPORT OF FOREIGN PRIVATE ISSUER

Dec 12, 2024

596.0 KB

424B5

Dec 9, 2024

0001213900-24-106939PROSPECTUS SUPPLEMENT

—

850.2 KB

6-K

Nov 13, 2024

0001213900-24-097143REPORT OF FOREIGN PRIVATE ISSUER

Nov 13, 2024

17.1 KB

6-K

Nov 1, 2024

0001213900-24-093481REPORT OF FOREIGN PRIVATE ISSUER

Nov 1, 2024

17.6 KB

25 filings shown